Tumor Necrosis Factor-Alpha in Normal and Diseased Brain: Conflicting Effects Via Intraneuronal Receptor Crosstalk?

References

• Ameloot P, Fiers W, De Bleser P, Ware CF, Vandenabeele P, Brouckaert P (2001). Identification of tumor necrosis fac-tor (TNF) amino acids crucial for binding to the murine p75 TNF receptor and construction of receptor-selective mutants. J Biol Chem 276: 37426–37430.
   Google Scholar
• Ariga T, Jarvis WD, Yu RK (1998). Role of sphingolipid-mediated cell death in neurodegenerative diseases. J Lipid Res 39: 1–16.
   PubMed Web of Science ®Google Scholar
• Askovic S, Favara C, McAtee FJ, Portis JL (2001). Increased expression of MIP-1 alpha and MIP-1 beta mRNAs in the brain correlates spatially and temporally with the spongiform neurodegeneration induced by a murine on-cornavirus. J Virol 75: 2665–2674.
   Google Scholar
• Bahr BA, Bendiske J, Brown QB, Munirathinam S, Caba E, Rudin M, Urwyler S, Sauter A, Rogers G (2002). Sur-vival signaling and selective neuroprotection through glutamatergic transmission. Exp Neurol 174: 37–47.
   PubMed Web of Science ®Google Scholar
• Baker SJ, Reddy EP (1998). Modulation of life and death by the TNF receptor superfamily. Oncogene 17: 3261–3270.
   PubMed Web of Science ®Google Scholar
• Barker V, Middleton G, Davey F, Davies AM (2001). TNF al-pha contributes to the death of NGF-dependent neurons during development. Nat Neurosci 4: 1194–1198.
   PubMed Web of Science ®Google Scholar
• Barone FC, Arvin B, White RF, Miller A, Webb CL, Willette RN, Lysko PG, Feuerstein GZ (1997). Tumor necrosis factor-a: a mediator of focal ischemic brain injury. Stroke 28: 1233–1244.
   PubMed Web of Science ®Google Scholar
• Bencsik A, Malcus C, Akaoka H, Giraudon P, Belin MF, Bernard A (1996). Selective induction of cytokines in mouse brain infected with canine distemper virus: struc-tural, cellular and temporal expression. J Neuroim-munol 65: 1–9.
   Google Scholar
• Bezzi P, Domercq M, Brambilla L, Galli R, Schols D, De Clercq E, Vescovi A, Bagetta G, Kollias G, Meldolesi J, Volterra A (2001). CXCR4-activated astrocyte glutamate release via TNF-alpha: amplification by microglia trig-gers neurotoxicity. Nat Neurosci 4: 702–710.
   PubMed Web of Science ®Google Scholar
• Boin F, Zanardini R, Pioli R, Altamura CA, Maes M, Gennarelli M (2001). Association between G308A tu-mor necrosis factor alpha gene polymorphism and schizophrenia. Mo/ Psychiatry 6: 79–82.
   Google Scholar
• Boka G, Anglade P, Wallach D, Javoy-Agid F (1994). Immunocytochemical analysis of TNF and its recep-tors in Parkinson's disease. Neurosci Lett 172: 151–154.
   PubMed Web of Science ®Google Scholar
• Bredow S, Guha-Thakurta N, Taishi P, Obal F Jr, Krueger JM (1997). Diurnal variations of tumor necrosis factor alpha mRNA and alpha-tubulin mRNA in rat brain. Neuroim-munomodulation 4: 84–90.
   Google Scholar
• Brink R, Lodish HF (1998). Tumor necrosis factor receptor (TNFR)-associated factor 2A (TRAF2A), a TRAF2 splice variant with an extended RING finger domain that in-hibits TNFR2-mediated NF-KB activation. J Biol Chem 273: 4129–4134.
   PubMedGoogle Scholar
• Bruce AJ, Boling W, Kindy MS, Peschon J, Kraemer PJ, Carpenter MK, Holtsberg FW, Mattson MP (1996). Al-tered neuronal and microglial responses to excitotoxic and ischemic brain injury in mice lacking TNF recep-tors. Nat Med 2: 788–794.
   PubMed Web of Science ®Google Scholar
• Brugg B, Michel PP, Agid Y, Ruberg M (1996). Ceramide induces apoptosis in cultured mesencephalic neurons. J Neurochem 66: 733–739.
   Google Scholar
• Carswell EA, Old LJ, Kassel RL, Green S, Fiore N, Williamson B (1975). An endotoxin-induced serum fac-tor that causes necrosis of tumors. Proc Natl Acad Sci USA 72: 3666–3670.
   PubMed Web of Science ®Google Scholar
• Casaccia-Bonnefil P, Gu C, Chao MV (1999). Neurotrophins in cell survival/death decisions. In: The functional roles of glial cells in health and disease. Matsas R, Tsacopoulos M (eds). Kluwer/Plenum: New York, pp 275–282.
   Google Scholar
• Castagne V, Lefevre K, Clarke PG (2001). Dual role of the NF-kappaB transcription factor in the death of immature neurons. Neuroscience 108: 517–526.
   Google Scholar
• Cermelli C, Jacobson S (2000). Viruses and multiple scle-rosis. Viral Immunol 13: 255–267.
   PubMed Web of Science ®Google Scholar
• Cheeran MC, Hu S, Yager SL, Gekker G, Peterson PK, Lokensgard JR (2001). Cytomegalovirus induces cy-tokine and chemokine production differentially in mi-croglia and astrocytes: antiviral implications. I Neuro-Virol 7: 135–147.
   Google Scholar
• Craig LE, Sheffer D, Meyer AL, Hauer D, Lechner F, Peterhans E, Adams RJ, Clements JE, Narayan O, Zink MC (1997). Pathogenesis of ovine lentiviral encephalitis: derivation of a neurovirulent strain by in vivo passage. J NeuroVirol 3: 417–427.
   Web of Science ®Google Scholar
• Dantzer R (2001). Cytokine-induced sickness behavior: where do we stand? Brain Behav Immun 15: 7–24.
   PubMed Web of Science ®Google Scholar
• Dawson TM (2002). Preconditioning-mediated neuropro-tection through erythropoietin? Lancet 359: 96–97.
   Google Scholar
• Digicaylioglu M, Lipton SA (2001). Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-kappaB signalling cascades. Nature 412: 641–647.
   PubMed Web of Science ®Google Scholar
• Dopp JM, Mackenzie GA, Otero GC, Merrill JE (1997). Dif-ferential expression, cytokine modulation, and specific functions of type-1 and type-2 tumor necrosis factor re-ceptors in rat glia. J Neuroimmunol 75: 104–112.
   PubMed Web of Science ®Google Scholar
• Eder J (1997). Tumour necrosis factor alpha and interleukin 1 signalling: do MAPKK kinases connect it all? Trends Pharmacol Sci 18: 319–322.
   PubMed Web of Science ®Google Scholar
• Epstein L, Gelbard HA (1999). HIV-1-induced neuronal in-jury in the developing brain. J Leukoc Biol 65: 453–457.
   PubMed Web of Science ®Google Scholar
• Estus S, Zaks WJ, Freeman RS, Gruda M, Bravo R, Johnson EM Jr (1994). Altered gene expression in neurons during programmed cell death: identification of c-jun as nec-essary for neuronal apoptosis. J Cell Biol 127 (6 Pt 1): 1717–1727.
   Google Scholar
• Eves EM, Skoczylas C, Yoshida K, Alnemri ES, Rosner MR (2001). FGF induces a switch in death receptor path-wasys in neuronal cells. J Neurosci 21: 4996–5006.
   PubMed Web of Science ®Google Scholar
• Feng P, Chan SH, Ooi EE, Soo MY, Loh KS, Wang D, Ren EC, Hu H (1999). Elevated blood levels of soluble tu-mor necrosis factor receptors in nasopharyngeal carci-noma: correlation with humoral immune response to lytic replication of Epstein-Barr virus. Int J Oncol 15: 167–172.
   PubMed Web of Science ®Google Scholar
• Fontaine V, Mohand-Said S, Hanoteau N, Fuchs C, Pfizenmaier K, Eisel U (2002). Neurodegenerative and neuroprotective effects of tumor necrosis factor (TNF) in retinal ischemia: opposite roles of TNF receptor 1 and TNF receptor 2. J Neurosci 22: 216.
   Web of Science ®Google Scholar
• Gary DS, Bruce-Keller AJ, Kindy MS, Mattson MP (1998). Ischemic and excitotoxic brain injury is enhanced in mice lacking the p55 tumor necrosis factor receptor. J Cereb Blood Flow Metab 18: 1283–1287.
   PubMed Web of Science ®Google Scholar
• Goswami R, Dawson G (2000). Does ceramide play a role in neural cell apoptosis? J Neurosci Res 60: 141–149.
   Google Scholar
• Grazia De Simoni M, Imeri L (1998). Cytokine-neurotransmitter interactions in the brain. Biol Signals Receptors 7: 33–44.
   Google Scholar
• Griffin DE (1997). Cytokines in the brain during viral in-fection: clues to HIV-associated dementia. J Clin Invest 100: 2948–2951.
   Google Scholar
• Ham J, Babij C, Whitfield J, Pfarr CM, Lallemand D, Yaniv M, Rubin LL (1995). A c-Jun dominant negative mutant protects sympathetic neurons against programmed cell death. Neuron 14: 927–939.
   Google Scholar
• Haviv R, Stein R (1999). Nerve growth factor inhibits apop-tosis induced by tumor necrosis factor in PC12 cells. J Neurosci Res 55: 269–277.
   PubMed Web of Science ®Google Scholar
• Hemmer B, Cepok S, Nessler S, Sommer N (2002). Patho-genesis of multiple sclerosis: an update on immunology. Curr Opin Neurol 15: 227–231.
   Google Scholar
• Hoffman PM, Dhib-Jalbut S, Mikovits JA, Robbins DS, Wolf AL, Bergey GK, Lohrey NC, Weislow OS, Ruscetti FW (1992). Human T-cell leukemia virus type I infection of monocytes and microglial cells in primary human cul-tures. Proc Nati Acad Sci USA 89: 11784–11788.
   Google Scholar
• Hu S, Sheng WS, Ehrlich LC, Peterson PK, Chao CC (2000). Cytokine effects on glutamate uptake by human astro-cytes. Neuroimmunomodulation 7: 153–159.
   PubMed Web of Science ®Google Scholar
• Iida R, Saito K, Yamada K, Basile AS, Sekikawa K, Takemura M, Fujii H, Wada H, Seishima M, Nabeshima T (2000). Suppression of neurocognitive damage in LP-BM5-infected mice with a targeted deletion of the TNF-alpha gene. FASEB J 14: 1023–1031.
   PubMed Web of Science ®Google Scholar
• Itzhaki RF, Dobson CB (2002). Alzheimer's disease and herpes. Can Med Assoc J167: 13.
   Google Scholar
• Jarskog LF, Xiao H, Wilkie MB, Lauder JM, Gilmore JH (1997). Cytokine regulation of embryonic rat dopamine and serotonin neuronal survival in vitro. Int j Dev Neu-rosci 15: 711–716.
   PubMed Web of Science ®Google Scholar
• Jones SJ, Ledgerwood EC, Prins JB, Galbraith J, Johnson DR, Pober JS, Bradley JR (1999). TNF recruits TRADD to the plasma membrane but not the trans-Golgi network, the principal subcellular location of TNF-R1. JImmunol 162: 1042–1048.
   PubMedGoogle Scholar
• Kassiotis G, Kollias G (2001). Uncoupling the proinflamma-tory from the immunosuppressive properties of tumor necrosis factor (TNF) at the p55 TNF receptor level: im-plications for pathogenesis and therapy of autoimmune demyelination. J Exp Med 193: 427–434.
   PubMed Web of Science ®Google Scholar
• Kim WG, Mahoney RP, Wilson B, Jeohn GH, Liu B, Hong JS (2000). Regional difference in susceptibility to lipopolysaccharide-induced neurotoxicity in the rat brain: role of microglia. J Neurosci 20: 6309–6316.
   PubMed Web of Science ®Google Scholar
• Knoblach SM, Fan L, Faden Al (1999). Early neuronal expression of tumor necrosis factor-a after experimen-tal brain injury contributes to neurological impairment. J Neuroimmunol 95: 115–125.
   PubMed Web of Science ®Google Scholar
• Koh C, Inoue A, Yamazaki M, Kim BS (2000). High-dose mouse i=unoglobulin G administration suppresses Theiler's murine encephalomyelitis virus-induced de-myelinating disease. J Neuroimmunol 108: 22–28.
   Google Scholar
• Kraus J, Kuehne BS, Tofighi J, Frielinghaus P, Stolz E, Blaes F, Laske C, Engelhardt B, Traupe H, Kaps M, Oschmann P (2002). Serum cytokine levels do not corre-late with disease activity and severity assessed by brain MRI in multiple sclerosis. Acta Neurol Scand 105: 300–308.
   Google Scholar
• Kronfol Z, Remick DG (2000). Cytokines and the brain: im-plications for clinical psychiatry. Am J Psychiatry 157: 683–694.
   PubMed Web of Science ®Google Scholar
• Krueger JM, Fang J, Taishi P, Chen Z, Kushikata T, Gardi J (1998). Sleep: a physiologic role for IL-1 beta and TNF-alpha. Ann NY Acad Sci 856: 148–159.
   PubMedGoogle Scholar
• Kustova Y, Espey MG, Sung EG, Morse D, Sei Y, Basile AS (1998). Evidence of neuronal degeneration in C57B1/6 mice infected with the LP-BM5 leukemia retrovirus mix-ture. Mol Chem Neuropathol 35: 39–59.
   Google Scholar
• Ledgerwood EC, Pober JS, Bradley JR (1999). Recent ad-vances in the molecular basis of signal transduction. Lab Invest 79: 1041–1450.
   PubMed Web of Science ®Google Scholar
• Licinio J, Wong ML (1997). Pathways and mechanisms for cytokine signaling of the central nervous system. J Clin Invest 100: 2941–2947.
   PubMed Web of Science ®Google Scholar
• Lin MT, Hinton DR, Parra B, Stohlman SA, van der Veen RC (1998). The role of IL-10 in mouse hepatitis virus-induced demyelinating encephalomyelitis. Virol-ogy 245: 270–280.
   Google Scholar
• Loddick SA, Rothwell NJ (1999). Mechanisms of tumor necrosis factor-a action on neurodegeneration: interac-tion with insulin-like growth factor-1. Proc Natl Acad Sci USA 96: 9449–9451.
   Google Scholar
• MacDonald NJ, Perez-Polo JR, Bennett AD, Taglialatela G (1999). NGF-resistant PC12 cell death induced by arachi-donic acid is accompanied by a decrease of active PKC zeta and nuclear factor kappa B. J Neurosci Res 57: 219–226.
   Google Scholar
• Maggirwar SB, Ramirez S, Tong N, Gelbard HA, Dewhurst S (2000). Functional interplay between nuclear factor-kappaB and c-Jun integrated by coactivator p300 de-termines the survival of nerve growth factor-dependent PC12 cells. j Neurochem 74: 527–539.
   PubMedGoogle Scholar
• Marchetti C, Ulisse S, Bruscoli S, Russo FP, Migliorati G, Schiaffella F, Cifone MG, Riccardi C, Fringuelli R (2002). Induction of apoptosis by 1,4-benzothiazine analogs in mouse thymocytes. J Pharmacol Exp Ther 300: 1053–1062.
   PubMed Web of Science ®Google Scholar
• Mattson MP, Barger SW, Furukawa K, Bruce AJ, Wyss-Cory T, Mark RJ, Mucke L (1997). Cellular signaling roles of TGFb, TNFa, and bAPP in brain injury responses and Alzheimer's disease. Brain Res Rev 23: 47–61.
   Google Scholar
• Mayne M, Ni W, Yan HJ, Xue M, Johnston JB, Del Bigio MR, Peeling J, Power C (2001). Antisense oligodeoxynu-cleotide inhibition of tumor necrosis factor-alpha ex-pression is neuroprotective after intracerebral hemor-rhage. Stroke 32: 240–248.
   PubMed Web of Science ®Google Scholar
• Molina-Holgado F, Hernanz A, De la Fuente M, Guaza C (1999). N-Acetyl-cysteine inhibition of encephalomyeli-tis Theiler's virus-induced nitric oxide and tumour necrosis factor-alpha production by murine astrocyte cultures. Biofactors 10: 187–193.
   Google Scholar
• Munoz-Fernandez MA, Fresno M (1998). The role of tu-mour necrosis factor, interleukin 6, interferon-gamma and inducible nitric oxide synthase in the development and pathology of the nervous system. Prog Neurobiol 56: 307–340.
   PubMed Web of Science ®Google Scholar
• Pan W, Zadina JE, Harlan RE, Weber JT, Banks WA, Kastin AJ (1997). Tumor necrosis factor-a: a neuromodulator in the CNS. Neurosci Biobehav Rev 21: 603–613.
   PubMed Web of Science ®Google Scholar
• Pelagi M, Cumis F, Colombo B, Rovere P, Sacchi A, Manfredi AA, Corti A (2000). Caspase inhibition reveals functional cooperation between p55- and p75-TNF re-ceptors in cell necrosis. Eur Cytokine Networks 11: 580–588.
   Google Scholar
• Perini G, Della-Bianca V, Politi V, Della Valle G, Dal-Pra I, Rossi F, Armato U (2002). Role of p75 neurotrophin receptor in the neurotoxicity by beta-amyloid peptides and synergistic effect of inflammatory cytokines. J Exp Med 195: 907–918.
   PubMed Web of Science ®Google Scholar
• Perry RT, Collins JS, Wiener H, Acton R, Go RC (2001). The role of TNF and its receptors in Alzheimer's disease. Neurobiol Aging 22: 873–883.
   PubMed Web of Science ®Google Scholar
• Peterson KE, Robertson SJ, Portis JL, Chesebro B (2001). Differences in cytokine and chemokine responses dur-ing neurological disease induced by polytropic murine retroviruses Map to separate regions of the viral enve-lope gene. J Virol 75: 2848–2856.
   PubMed Web of Science ®Google Scholar
• Plata-Salaman CR, Oomura Y, Kai Y (1988). Tumor necrosis factor and interleukin-1 beta: suppression of food intake by direct action in the central nervous system. Brain Res 448: 106–114.
   PubMed Web of Science ®Google Scholar
• Poli A, Pistello M, Carli MA, Abramo F, Mancuso G, Nicoletti E, Bendinelli M (1999). Tumor necrosis factor-alpha and virus expression in the central nervous sys-tem of cats infected with feline immunodeficiency virus. J NeuroVirol 5: 465–473.
   Google Scholar
• Rath PC, Aggarwal BB (1999). TNF-induced signaling in apoptosis. J Clin Immunol 19: 350–364.
   PubMed Web of Science ®Google Scholar
• Rauca C, Zerbe R, Jantze H, Krug M (2000). The importance of free hydroxyl radicals to hypoxia preconditioning. Brain Res 868: 147–149.
   Google Scholar
• Rothwell N, Allan S, Toulmond S (1997). The role of interleukin 1 in acute neurodegeneration and stroke: pathophysiological and therapeutic implications. J Clin Invest 100: 2648–2652.
   PubMed Web of Science ®Google Scholar
• Ryan LA, Zheng J, Brester M, Bohac D, Hahn F, Anderson J, Ratanasuwan W, Gendelman HE, Swindells S (2001). Plasma levels of soluble CD14 and tumor necrosis factor-alpha type II receptor correlate with cognitive dysfunc-tion during human immunodeficiency virus type 1 in-fection. J Infect Dis 184: 699–706.
   PubMed Web of Science ®Google Scholar
• Scherbel U, Raghupathi R, Nakamura M, Saatman KE, McIntosh TK (1997). Evaluation of neurobehavioral deficits in brain injured tumor necrosis factor-deficient (TNF-/-) mice after experimental brain injury. J Neu-rotmuma 14: 781.
   Google Scholar
• Sei Y, Nishida K, Kustova Y, Markey SP, Morse HC 3rd, Basile AS (1997). Pentoxifylline decreases brain levels of platelet activating factor in murine AIDS. Eur J Phar-macol 325: 81–84.
   Google Scholar
• Shinmura Y, Kosugi I, Kaneta M, Tsutsui Y (1999). Migra-tion of virus-infected neuronal cells in cerebral slice cul-tures of developing mouse brains after in vitro infection with murine cytomegalovirus. Acta Neuropathol (Berl) 98: 590–596.
   Google Scholar
• Shinpo K, Kikuchi S, Moriwaka F, Tashiro K (1999). Protec-tive effects of the TNF-ceramide pathway against gluta-mate neurotoxicity on cultured mesencephalic neurons. Brain Res 819: 170–173.
   PubMed Web of Science ®Google Scholar
• Shohami E, Ginis I, Hallenback JM (1999). Dual role of tumor necrosis factor alpha in brain injury. Cytokine Growth Factor Rev 10: 119–130.
   PubMed Web of Science ®Google Scholar
• Sipe KJ, Dantzer R, Kelley KW, Weyhenmeyer JA (1998). Expression of the 75kDA TNF receptor and its role in contact mediated neuronal cell death. Mol Brain Res 62: 111–121.
   Google Scholar
• Spiegel S, Cuvillier O, Edsall LC, Kohama T, Menzeleev R, Olah Z, Olivera A, Pirianov G, Thomas DM, Tu Z, Van Brocklyn JR, Wang F (1998). Sphingosine-1-phosphate in cell growth and cell death. Ann NY Acad Sci 845: 11–18.
   PubMed Web of Science ®Google Scholar
• Sternberg EM (1997). Neural-immune interactions in health and disease. J Clin Invest 100: 2641–2647.
   PubMed Web of Science ®Google Scholar
• Stoll G, Jander S, Schroeter M (2000). Cytokines in CNS disorders: neurotoxicity versus neuroprotection. J Neu-ral Transm Suppl 59: 81–89.
   Google Scholar
• Sun N, Grzybicki D, Castro RF, Murphy S, Perlman S (1995). Activation of astrocytes in the spinal cord of mice chron-ically infected with a neurotropic coronavirus. Virology 213: 482–493.
   Google Scholar
• Takano R, Hisahara S, Namikawa K, Kiyama H, Okano H, Miura M (2000). Nerve growth factor protects oligo-dendrocytes from tumor necrosis factor-a-induced in-jury through Akt-mediated signaling mechanisms. J Biol Chem 275: 16360–16365.
   Google Scholar
• Tong CY, Bakran A, Williams H, Cuevas LE, Peiris JS, Hart CA (2001). Association of tumour necrosis factor al-pha and interleukin 6 levels with cytomegalovirus DNA detection and disease after renal transplantation. J Med Virol 64: 29–34 .
   PubMedGoogle Scholar
• Trgovcich J, Aronson JF, Eldridge JC, Johnston RE (1999). TNF-alpha, interferon, and stress response induction as a function of age-related susceptibility to fatal Sindbis virus infection of mice. Virology 263: 339–348.
   Google Scholar
• Ubalee R, Suzuki F, Kikuchi M, Tasanor O, Wattanagoon Y, Ruangweerayut R, Na-Bangchang K, Karbwang J, Kimura A, Itoh K, Kanda T, Hirayama K (2001). Strong association of a tumor necrosis factor-alpha promoter al-lele with cerebral malaria in Myanmar. Tissue Antigen 58: 407–410.
   Google Scholar
• Venters HD, Tang Q, Liu Q, VanHoy RW, Dantzer R, Kelley KW (1999). A new mechanism of neurodegeneration: a proinfla=atory cytokine inhibits receptor signaling by a survival peptide. Proc Natl Acad Sci USA 96: 9879–9884.
   PubMed Web of Science ®Google Scholar
• Verreault R, Laurin D, Lindsay J, De Serres G (2001). Past exposure to vaccines and subsequent risk of Alzheimer's disease. Can Med Assoc J165: 1495–1498.
   Google Scholar
• Vitkovic L, Bockaert J, Jacque C (2000). "Inflammatory" cy-tokines: neuromodulators in normal brain?J Neurochem 74: 457–471.
   Google Scholar
• Wang E, Marcotte R, Petroulakis E (1999). Signaling path-way for apoptosis: a racetrack for life or death. J Cell Biochem Suppl 32/33: 95–102.
   Google Scholar
• Wesselingh SL, Power C, Glass JD, Tyor WR, MacArthur JC, Farber JM, Griffin JW, Griffin DE (1993). Intracere-bral cytokine messenger RNA expression in acquired immune deficiency syndrome dementia. Ann Neurol 33: 576–582.
   PubMedGoogle Scholar
• Wilde GJ, Pringle AK, Sundstrom LE, Mann DA, Iannotti F (2000). Attenuation and augmentation of ischaemia-related neuronal death by tumour necro-sis factor-alpha in vitro. Eur J Neurosci 12: 3863–3870.
   PubMed Web of Science ®Google Scholar
• Yang L, Lindholm K, Konishi Y, Li R, Shen Y (2002). Tar-get depletion of distinct tumor necrosis factor receptor subtypes reveals hippocampal neuron death and sur-vival through different signal transduction pathways. J Neurosci 22: 3025–3032.
   PubMed Web of Science ®Google Scholar
• Yolken RH, Karlsson H, Yee F, Johnston-Wilson NL, Torrey EF (2000). Endogenous retroviruses and schizophrenia. Brain Res Rev 31: 193–199.
   PubMedGoogle Scholar